Indivior stock: company declares conditional USD 8.13 special dividend

Indivior Pharmaceuticals declared a conditional USD 8.13 special dividend. Payment depends on completion of the proposed merger with Supernus Pharmaceuticals.

Indivior Pharmaceuticals, Inc. announced on September 17, 2026, that its board had declared a special cash dividend of USD 8.13 per share. The payment is conditional on the completion of the company’s proposed merger with Supernus Pharmaceuticals.

Dividend depends on merger closing

Indivior said the special dividend would be payable to holders of record as of October 30, 2026, and would also apply to certain equity awards outstanding on that date. The company will not pay the dividend if the merger is not completed.

Expected payment date

Indivior’s release said the merger is expected to close on or about November 2, 2026, subject to required approvals and other closing conditions. Assuming completion on that date, payment of the special dividend is anticipated on or about November 6, 2026.